leisure time -WSS

leisure time

author：focus 2025-09-29 22:47:24 - browse：58152

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Impact of Dobbs ruling felt at reproductive medicine meeting

entertainment

WSS

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

STAT Summit: How a Chicago ER doctor tackles gun violence

Psychedelics group wrestles with new pharma identity

In Memoriam: Notable people who died in 2023

Why health workers in Gaza are injured or die at high rates

The EU Joint Clinical Assessment needs to live up to its promise

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

STAT Summit: How a Chicago ER doctor tackles gun violence

How one medical school became remarkably diverse

At least 13 dead in Texas as scorching temps continue

At least 13 dead in Texas as scorching temps continue

STAT Summit: GSK CEO on pharma giant's new direction

The high cost of giving birth even with insurance

Apple is now the first public company to be valued at $3 trillion

After affirmative action ruling, medical educators look to 'holistic review'

STAT Summit: How a Chicago ER doctor tackles gun violence

entertainment

Pharmacists can make shortage drugs, but at what cost?

23andMe had bad news about my health. I wish a person had delivered it

Lawmakers consider Medicare pay reforms for doctors

CEOs share strategies for surviving biotech slump

UnitedHealth’s board chair also owns a personal investment firm

At least 13 dead in Texas as scorching temps continue

focus

entertainment

focus

hotspot